371463 PAT Implementation and QbD Control Strategy for Commercial Production of a Drug Substance

Wednesday, November 19, 2014: 4:30 PM
203 (Hilton Atlanta)
Elie Chaaya1, Zhihao Lin1, George Zhou2, Sun Lei3, Tseng-En Hu4, Busolo Wabuyele2 and Cindy Starbuck5, (1)PAT, Merck & Co. Inc., Rahway, NJ, (2)PAT, Merck, Rahway, NJ, (3)Merck, rahway, NJ, (4)PAT, Merck, RAhway, NJ, (5)CERD, Merck & Co., Rahway, NJ

Abstracts:


Extended Abstract: File Not Uploaded
See more of this Session: PAT for Process Understanding and Elucidation of Fundamental Phenomena in Drug Product/Substance Development
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum